{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:51:45Z","timestamp":1784695905163,"version":"3.55.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Surveillance of incidence and severity of pertussis is key to control success and shortcomings of vaccination programs followed by adaptations of recommendations if necessary. In Switzerland, nationwide reporting of hospitalizations due to pertussis in children has a long tradition and resumed in 2013 to evaluate the effects of pertussis immunization in pregnancy introduced in 2013.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Since 2013, all patients &lt;16 years of age hospitalized with suspected or proven pertussis have been reported to the Swiss Pediatric Surveillance Unit. Patient data comprising clinical and epidemiologic characteristics and laboratory confirmation were assessed in a standardized fashion, and case definitions were applied to all cases reported until the end of 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Two hundred thirteen of 294 cases were valid cases of pertussis. Of these, 168 (79%) occurred in &lt;6-month-old infants. Mean duration of hospitalization was 8 days (median 5, range 2\u201347) overall and highest in neonates (14.2 days); 85% of all patients had \u22651 complication, most commonly cyanosis and dyspnea, especially in infants. Overall, case fatality rate was 1.4% (8.7% in neonates). Only 4 (2%) of 168 mothers of infants &lt;6 months had been vaccinated during pregnancy; 14 (12%) of 112 patients with precise records of immunization had completed their primary series and were up-to-date for age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Despite a decline of cases associated with the introduction of immunization against pertussis in pregnancy, control of the disease remains challenging, mainly due to failure to vaccinate rather than vaccine failure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002904","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T21:05:02Z","timestamp":1600463102000},"page":"22-25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and Epidemiologic Characteristics of Pertussis in Hospitalized Children: A Prospective and Standardized Long-term Surveillance Study"],"prefix":"10.1097","volume":"40","author":[{"given":"Jana","family":"Zumstein","sequence":"first","affiliation":[{"name":"Paediatric Infectious Diseases and Vaccinology Unit, University of Basel Children\u2019s Hospital, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases and Vaccinology Unit, University of Basel Children\u2019s Hospital, Basel, Switzerland"},{"name":"Faculty of Medicine, University of Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"R2-20250615","first-page":"433","article-title":"Pertussis vaccines: WHO position paper\u2014September 2015.","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"20414","DOI":"10.2807\/ese.18.09.20414-en","article-title":"The number of deaths among infants under one year of age in England with pertussis: results of a capture\/recapture analysis for the period 2001 to 2011.","volume":"18","author":"van Hoek","year":"2013","journal-title":"Euro Surveill"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02113254","article-title":"Serious pertussis overlooked in infants.","volume":"151","author":"Heininger","year":"1992","journal-title":"Eur J Pediatr"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14787210.2016.1190272","article-title":"Surveillance of pertussis: methods and implementation.","volume":"14","author":"Guiso","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1016\/j.vaccine.2018.10.028","article-title":"Recommendations to control pertussis prioritized relative to economies: a Global Pertussis Initiative update.","volume":"36","author":"Forsyth","year":"2018","journal-title":"Vaccine"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.vaccine.2011.01.017","article-title":"Prospective pertussis surveillance in Switzerland, 1991-2006.","volume":"29","author":"Wymann","year":"2011","journal-title":"Vaccine"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.inf.0000435503.44620.74","article-title":"Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006-2010.","volume":"33","author":"Heininger","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20250615","first-page":"118","article-title":"Anpassung der Impfempfehlung gegen Pertussis: f\u00fcr Jugendliche, S\u00e4uglinge in Betreuungseinrichtungen und schwangere Frauen.","volume":"9","year":"2013","journal-title":"Bull BAG"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion.","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study.","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/cid\/cix724","article-title":"Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation.","volume":"65","author":"Skoff","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/cid\/ciz217","article-title":"Maternal vaccination in Argentina: tetanus, diphtheria, and acellular pertussis vaccine effectiveness during pregnancy in preventing pertussis in infants <2 months of age.","volume":"70","author":"Romanin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"e20164091","DOI":"10.1542\/peds.2016-4091","article-title":"Effectiveness of vaccination during pregnancy to prevent infant pertussis.","volume":"139","author":"Baxter","year":"2017","journal-title":"Pediatrics"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"30545","DOI":"10.2807\/1560-7917.ES.2017.22.22.30545","article-title":"A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016.","volume":"22","author":"Bellido-Blasco","year":"2017","journal-title":"Euro Surveill"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study.","volume":"36","author":"Saul","year":"2018","journal-title":"Vaccine"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1016\/j.vaccine.2019.03.049","article-title":"The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: a case-control study.","volume":"37","author":"Fernandes","year":"2019","journal-title":"Vaccine"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2019.11.069","article-title":"Dose-dependent effectiveness of acellular pertussis vaccine in infants: a population-based case-control study.","volume":"38","author":"Mack","year":"2020","journal-title":"Vaccine"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"100013","DOI":"10.1016\/j.jvacx.2019.100013","article-title":"Child-parent immunization survey: how well are national immunization recommendations accepted by the target groups?","volume":"1","author":"Erb","year":"2019","journal-title":"Vaccine X"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/INF.0000000000001767","article-title":"Is there a need for a stand-alone acellular pertussis vaccine?","volume":"37","author":"Heininger","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review.","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","article-title":"Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents.","volume":"164","author":"Bonhoeffer","year":"2005","journal-title":"Eur J Pediatr"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2004-2648","article-title":"The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection.","volume":"115","author":"Cherry","year":"2005","journal-title":"Pediatrics"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: a case-control study.","volume":"61","author":"Winter","year":"2015","journal-title":"Clin Infect Dis"}],"updated-by":[{"DOI":"10.1097\/inf.0000000000003431","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:04:50Z","timestamp":1750003490000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002904","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,16]]}}}